Recently, an interesting post in the stock bar has aroused the interest of the majority of investors. In the post, the secretary of the board of directors shook two phone calls: "The chairman and general manager decided to increase their holdings of listed companies out of their own pockets within a few minutes." According to the company's recent announcement, Mr. Fu Heliang, one of the actual controllers of the company and chairman of the board, and Mr. Zhang Jie, director and president of the company, intend to increase their holdings of the company's shares through the methods permitted by the trading system of the Shanghai Stock Exchange (including but not limited to centralized bidding and block trading) within 6 months from July 4, 2024, with a total increase of not less than RMB 5 million and no more than RMB 10 million.
As early as May 2022 to November 2022, Mr. Fu Heliang has used his own funds to increase his holdings of 1,374,783 shares of the company, with a total amount of 13.4233 million yuan; From October 2023 to April 2024, Mr. Fu Heliang increased his holdings of 589,700 shares of the company, with a total amount of 7.6449 million yuan. The total amount of the two increases has exceeded 21 million yuan. This is the third time that the chairman of the company has increased his holdings.
Mr. Zhang Jie joined Eddy Pharmaceutical in March last year, and it has only been more than a year, and both of them have increased their holdings to confirm their confidence in the company's long-term improvement.
In such a weak secondary market, what is the short-term high-frequency increase in the company's shares?
Let's sort it out, according to public information, Aidi Pharmaceutical is an innovative drug company with the most complete HIV pipeline layout in China. The core products under development include 8 Category 1 new drugs and 4 Category 2 new drugs, covering anti-HIV non-nucleoside reverse transcriptase inhibitors, integrase inhibitors, long-acting therapeutic drugs, inflammation, stroke and other therapeutic fields, some of which are innovative varieties that fill the domestic gap, have significant efficacy and good market prospects. Recently, it has released an announcement on the integration of the business model for the development of the collaborative industry and the acquisition of major assets in the human protein industry chain.
Generally speaking, shareholder increase and company self-help repurchase are two different concepts, the former is more optimistic about the later development of their own enterprises, and may also obviously feel that their stock price is undervalued. Whatever the reason, regulators and investors are willing to see companies increase their holdings of their own stocks. On the second day of the announcement of the increase in holdings, the share price of Aidi Pharmaceutical rose sharply after the opening of the market, leading the rise in the biological products sector, closing at 10.12 yuan per share, an increase of 10.6%.
What's even more interesting is that after the announcement of the increase in holdings, the voices of praise came one after another. We saw feedback from investors in the E-Interaction question.
According to statistics, in June this year, important shareholders in the A-share market increased their holdings by 9.1 billion yuan. As of June 25, more than 360 listed companies in the A-share market have issued shareholder shareholding plans during the year, with a total amount of 20 billion yuan to be invested. The market is not cold-blooded, there is a return on pay, and the benefits of shareholders' own pockets are proper over-the-counter funds, which is the confidence in the company's future development and the recognition of the company's long-term investment value, and is also to further enhance investor confidence, safeguard the interests of the company and all shareholders, and promote the company's sustainable, stable and healthy development. We hope that more and more board secretaries can advocate to increase their own holdings, and we hope that A-shares will be as prosperous as the motherland.